A Study Utilizing Patient-Reported Outcomes to Evaluate the Safety and Efficacy of Lorecivivint (SM04690) for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis (STRIDES)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Yusuf Yazici, MD
Biosplice Therapeutics, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
44 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tucson Orthopaedic Institute
Tucson, Arizona, United States
- Core Healthcare Research
Cerritos, California, United States
- Biosolutions Clinical Research Center
La Mesa, California, United States
- Infinity Clinical Research
Norco, California, United States
- Dream Team Clinical Research
Pomona, California, United States
- Artemis Institute for Clinical Research
San Diego, California, United States
- Encompass Clinical Research
Spring Valley, California, United States
- Millennium Clinical Trials, Llc
Thousand Oaks, California, United States
- Unique Clinical Trials
Doral, Florida, United States
- Eastern Research, Inc.
Hialeah, Florida, United States
- Tectum Research
Hollywood, Florida, United States
- Advance Medical Research Center
Miami, Florida, United States
- Applemed Research Group, Llc
Miami, Florida, United States
- Biomed Research and Medical Center
Miami, Florida, United States
- Columbus Clinical Services, Llc
Miami, Florida, United States
- Health and Life Research Institute, Llc
Miami, Florida, United States
- Well Pharma Medical Research, Corp
Miami, Florida, United States
- South Florida Research Phase I-Iv, Inc.
Miami Springs, Florida, United States
- Tampa Pain Relief Center
Tampa, Florida, United States
- Premier Medical Associates
The Villages, Florida, United States
- Conquest Research, Llc
Winter Park, Florida, United States
- Pinnacle Trials, Inc.
Stockbridge, Georgia, United States
- Chicago Clinical Research Institute
Chicago, Illinois, United States
- Medisphere Medical Research Center, Llc
Evansville, Indiana, United States
- Delricht Research - Mandeville
Mandeville, Louisiana, United States
- Delricht Research
New Orleans, Louisiana, United States
- Delricht Research - Prairieville
Prairieville, Louisiana, United States
- Delricht Research - Rockville
Rockville, Maryland, United States
- Skylight Health Research
Burlington, Massachusetts, United States
- Oakland Medical Research
Troy, Michigan, United States
- Healthcare Research Network
Hazelwood, Missouri, United States
- Albuquerque Clinical Trials
Albuquerque, New Mexico, United States
- Hightop Medical Research Center
Cincinnati, Ohio, United States
- Conrad Clinical Research
Edmond, Oklahoma, United States
- Delricht Research - Tulsa
Tulsa, Oklahoma, United States
- Clinical Trials of South Carolina
Charleston, South Carolina, United States
- Piedmont Research Partners, Llc
Fort Mill, South Carolina, United States
- Health Concepts
Rapid City, South Dakota, United States
- Zenos Clinical Research
Dallas, Texas, United States
- Synergy Groups Medical, Llc
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Nov 2022
- Primary completion
- 20 Feb 2024
- Completion
- 20 Feb 2024
- Last update posted
- 25 Jul 2024
- Registered enrollment
- 496
- Registry id
- NCT05603754
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.